SuperworthFoghorn Therapeutics shares outstanding FHTX
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 70.6M
- On a year earlier
- +12.1%
- more shares
Foghorn Therapeutics had 70.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 12.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 63.1M | +0% |
| FY2024 | 62.8M | +49% |
| FY2023 | 42.2M | +1% |
| FY2022 | 41.8M | +10% |
| FY2021 | 38M | +38% |
| FY2020 | 27.6M | +480% |
| FY2019 | 4.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 70.6M | +12% | |
| Q1 FY26 | 69.5M | +11% | |
| Q4 FY25 | 63.1M | +0% | |
| Q3 FY25 | 63M | +1% | |
| Q2 FY25 | 63M | +22% | |
| Q1 FY25 | 62.8M | +48% | |
| Q4 FY24 | 62.8M | +49% | |
| Q3 FY24 | 62.6M | +49% | |
| Q2 FY24 | 51.6M | +23% | |
| Q1 FY24 | 42.4M | +1% | |
| Q4 FY23 | 42.2M | +1% | |
| Q3 FY23 | 42M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Foghorn Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.